Figure 7.
Hepcidin antagonist pretreatment reduces Sorafenib-induced cell death in HCC cells. HepG2 and Huh7 cells were pre-treated with Fursultiamine (10 µM) for 30 minutes, followed by Sorafenib (5 µM) treatment for 24 h. Cells were harvested for trypan blue exclusion assay (A) or western blot assays with the antibodies as indicated (B, C). Actin blots served as the protein loading control. The asterisk indicates a significant difference compared to the DMSO control (p < 0.05, Student t-test).